Gandhi Balaji
Transaction: 09/01/2026
BUY
Change
+192,000
Price
Not reported
Filing
09/03/2026
Type
BUY
Phreesia, Inc.
PHR • Medical - Healthcare Information Services
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jul 31, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$686.11M
Growth
-20.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 17.1%Positive free cash flow · 1.13Manageable debt level · 0.3Healthy liquidity · 1.53Expensive earnings multiple · 347.91
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$686.11M
52W Range7.77 - 30.43
Beta0.84
Gross Margin67.93%
Oper. Margin-1.38%
Profit Margin0.48%
Debt/Eq0.30
Current Ratio1.53
Quick Ratio1.53
Revenue 5Y-20.78%
Price$0.00
Change0.00%
Market Cap$686.11M
52W Range7.77 - 30.43
Beta0.84
Gross Margin67.93%
Oper. Margin-1.38%
Profit Margin0.48%
Debt/Eq0.30
Current Ratio1.53
Quick Ratio1.53
Revenue 5Y-20.78%
Target$12.33
Target Median$12.00
Target Range10.00 - 16.00
Volume1.26M
Avg Volume1.12M
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
63
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
60/100
Why this score▼
Positive revenue growth · 17.1%Positive free cash flow · 1.13Manageable debt level · 0.3Healthy liquidity · 1.53Expensive earnings multiple · 347.91
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-04
Low
$10.00
Mean
$12.33
Median
$12.00
High
$16.00
Insider Transactions
Recent executive and insider activity
Hoffman Allison C
Transaction: 09/01/2026
BUY
Change
+108,000
Price
Not reported
Filing
09/03/2026
Type
BUY
Hui Yvonne
Transaction: 09/01/2026
BUY
Change
+43,000
Price
Not reported
Filing
09/03/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Gandhi Balaji | BUY | +192,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Hoffman Allison C | BUY | +108,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Hui Yvonne | BUY | +43,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Indig Chaim | BUY | +500,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Roberts Evan | BUY | +192,000 | Not reported | 09/01/2026 | 09/03/2026 |
| VanDuyn Amy Beth | BUY | +88,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Linetsky David | BUY | +10,000 | Not reported | 09/01/2026 | 09/03/2026 |
| Linetsky David | SELL | -182 | $12.28 | 08/14/2026 | 08/17/2026 |
| Goldstein Lainie | BUY | +377 | $10.73 | 07/31/2026 | 08/03/2026 |
| Munson Gillian | BUY | +685 | $10.73 | 07/31/2026 | 08/03/2026 |
| Hui Yvonne | SELL | -1,247 | $10.92 | 07/16/2026 | 07/17/2026 |
| Hui Yvonne | SELL | -937 | $10.76 | 07/15/2026 | 07/17/2026 |
| Linetsky David | SELL | -69 | $10.76 | 07/15/2026 | 07/17/2026 |
| Egbuonu-Davis Lisa | SELL | -536 | $10.70 | 07/14/2026 | 07/16/2026 |
| Hui Yvonne | SELL | -1,371 | $10.84 | 07/06/2026 | 07/07/2026 |
| Hui Yvonne | BUY | +1,371 | $8.75 | 06/30/2026 | 07/02/2026 |
| Hoffman Allison C | BUY | +1,265 | $8.75 | 06/30/2026 | 07/02/2026 |
| Egbuonu-Davis Lisa | SELL | -2,546 | $9.53 | 06/25/2026 | 06/26/2026 |
| Goldstein Lainie | BUY | +19,290 | $9.59 | 06/24/2026 | 06/26/2026 |
| Smith Mark Douglas | BUY | +19,290 | $9.59 | 06/24/2026 | 06/26/2026 |